Zdrowie i gospodarka · 03/03/2015

Measuring Dystrophin in Dystrophinopathy Patients and Interpreting the Data: Public Scientific Workshop Request for Comments

The Food and Drug Administration (FDA) is hosting a public scientific workshop to discuss measuring dystrophin in dystrophinopathy patients and will accept electronic comments until May 20, 2015, at http://www.regulations.gov. Written comments can also be submitted to the FDA's Division of Dockets Management, with a deadline of May 20, 2015.